Cryoport, Inc. (NasdaqCM: CYRX)
Health Care · Life Sciences Tools & Services · US
$16.96
-2.25% today · +86.6% 1Y
Cryoport, Inc. (NasdaqCM: CYRX) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $878.76M and employs 688 people.
Over the last twelve months the share price has gained 86.6%, trading between 7.61 and 18.36.
Tweenvest scores Cryoport, Inc. across four factors: quality 55/100, value 51/100, growth 0/100. Its strongest factor is quality.
CYRX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $878.76M
- Revenue (TTM)
- $186.45M
- P/E
- —
- EPS
- -0.91
- Dividend yield
- —
- Beta (5Y)
- 1.96
- 52-week high
- $18.36
- 52-week low
- $7.61
- Avg volume (3M)
- —
- Shares outstanding
- 50.65M
- Employees
- 688
- Next earnings
- —
About Cryoport, Inc.
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
- ISIN
- US2290503075
- Founded
- 1999
- Listed since
- Aug 22, 2005
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PharmaResources (Shanghai) Co., Ltd.SZSE: 301230 | $974.39M | CN¥36.42 | -5.35% |
| Anhui Wanbang Pharmaceutical Technology Co.,Ltd.SZSE: 301520 | $960.20M | CN¥69.33 | -2.42% |
| Shanghai Runda Medical Technology Co., Ltd.SHSE: 603108 | $899.94M | CN¥9.97 | -0.10% |
| R&G PharmaStudies Co., Ltd.SZSE: 301333 | $887.87M | CN¥62.08 | -6.88% |
| Ginkgo Bioworks Holdings, Inc.NYSE: DNA | $875.42M | $11.61 | -10.69% |
| Maccura Biotechnology Co.LtdSZSE: 300463 | $864.83M | CN¥9.58 | +0.52% |
| Suven Life Sciences LimitedBSE: 530239 | $825.52M | Rs282.75 | -8.35% |
| Shanghai Obio Technology (Group) Corp., Ltd.SHSE: 688238 | $807.40M | CN¥8.58 | -3.05% |
Figures last refreshed Oct 11, 2026.